Navigation Links
Resverlogix desincorpora RVX Therapeutics Inc. para sus accionistas
Date:4/8/2013

ting dates are anticipated to be on or around April 25, 2013 and May 28, 2013, respectively. A management information circular containing a complete description of the Arrangement and a description of tax implications to shareholders will be sent to shareholders of Resverlogix in connection with the special meeting to approve the Arrangement.

No se podrá asegurar o garantizar que la desincorporación se lleve a cabo.

Resverlogix celebrará una rueda de prensa en directo y emisión web con preguntas y respuestas a las 11 a.m. MDT del 8 de abril de 2013.

Enlace a la emisión web:

http://services.choruscall.ca/links/resverlogix130408.html

Números de llamada de la rueda de prensa:

Canadá y Estados Unidos, número gratuito: 1-800-319-4610

Fuera de Canadá y Estados Unidos llame al número: +1-604-638-5340

Acerca de Resverlogix Corp.

Resverlogix Corp. (TSX:RVX) es una compañía cardiovascular en fase clínica con una tecnología de plataforma epigenética que modula la producción de proteína. Resverlogix está desarrollando RVX-208, una molécula pequeña de primera clase para el tratamiento de la ateroesclerosis. RVX-208 es el primer inhibidor de bromodominio BET en ensayos clínicos. Los nuevos compuestos que surgen de la plataforma de descubrimiento de fármaco epigenético de Resverlogix funcionan por medio de la inhibición de los bromodominios BET, y cuentan con el potencial para impactar en múltiples enfermedades, incluyendo el cáncer, enfermedades neurodegenerativas y diabetes mellitus. Las acciones ordinarias de Resverlogix Corp. cotizan en la Bolsa de Valores de Toronto (TSX: RVX). Si desea más información visite la página web http://www.res
'/>"/>

SOURCE Resverlogix Corp.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Galectin Therapeutics: Turning Atlanta into Americas Next Silicon Valley
2. Galectin Therapeutics Reports Full Year and Fourth Quarter 2012 Financial Results
3. Aratana Therapeutics Adds To Drug Development Team
4. Biovista und DART Therapeutics nehmen Zusammenarbeit auf, um auf Duchenne-Muskeldystrophie abzielende Medikamente neu zu positionieren
5. Novira Therapeutics Completes $25 Million Series A Financing
6. Peptide Therapeutics Market is Expected to Reach USD 25.4 Billion Globally in 2018: Transparency Market Research
7. Pain Therapeutics - Drugs, Markets and Companies - 2013 Report
8. Genedata Expressionist for Mass Spectrometry Showcased at 2013 Biotherapeutics Analytical Summit
9. Array Biopharma and Global Blood Therapeutics Announce Drug Discovery Collaboration Focused on Hematology
10. Comprehensive Global Testing Solutions for Novel Hepatitis C Therapeutics, New Webinar Hosted by Xtalks
11. United Therapeutics Corporation To Announce Fourth Quarter And Annual 2012 Financial Results Before Market Open On Tuesday, February 26, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 The Pittcon Organizing Committee is pleased ... Safety Tech , an e-Journal and producer of ... the second year for the co-location of Food Labs Conference ... provides that the registration fee to attend the two-day Food ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 Look inside ... hard-working items for the lab, from fluid handling to ... (GIS)—ready to ship when you order. , Preferred ... Pumps , from the L/S® model for precise flow ...
(Date:1/15/2014)... California , January 15, 2014 Oxford ... today announced the appointment of Thomas C Reynolds MD, PhD ... years, development experience gained in the biotechnology industry, most recently ... am delighted to welcome Tom at this transformative time for ...
(Date:1/15/2014)... This webinar will focus on EMA ... assessment in biosimilars. , Regulatory frameworks are evolving many ... however the complex nature of biopharmaceuticals makes the demonstration ... extremely challenging. Based on the specific aspects of biosimilar ...
Breaking Biology Technology:Pittcon Announces Second Year Partnership With Food Safety Tech 2Pittcon Announces Second Year Partnership With Food Safety Tech 3Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2
... facilities, HR,occupational health, and safety professionals are already ... June 24, 2008 at the,American Conference Center, New ... the EEC, is,providing a new one-day conference format ... EEC alumni. The new format, which provides a ...
... (OTC Bulletin Board: DSCI), a provider of advanced wound ... an increase of 22 percent,over the $27.9 million reported ... due primarily to the costs of bringing in new ... sales staffs, the,Company reported a loss of $2.3 million ...
... April 1, 2008 Piedmont Heart Institute (PHI),expands ... cardiovascular,physician practice, Cardiology of Georgia, P.C. (COG), through ... 2008. With eight,locations including Buckhead, Canton, Fayetteville and ... under the Piedmont Heart Institute and an,important addition ...
Cached Biology Technology:Eastern Ergonomics Conference, June 24 in New York City; New One-Day Format, Focus on Core Ergonomics Education 2Derma Sciences Reports Fourth Quarter Year-End Results for 2007 2Derma Sciences Reports Fourth Quarter Year-End Results for 2007 3Derma Sciences Reports Fourth Quarter Year-End Results for 2007 4Derma Sciences Reports Fourth Quarter Year-End Results for 2007 5Piedmont Heart Institute Welcomes Cardiology of Georgia 2Piedmont Heart Institute Welcomes Cardiology of Georgia 3Piedmont Heart Institute Welcomes Cardiology of Georgia 4
(Date:7/9/2014)... Bacteria found in the bladders of healthy women ... form of incontinence, according to researchers from Loyola ... These findings, published July 9, 2014, in the ... , suggest that bacterial communities may play a ... incontinence (UUI) is a common, yet poorly understood, ...
(Date:7/9/2014)... the geographic ranges in which animals can be found, ... parasites. Does an increased range for a host mean ... necessarily, says a team of UC Santa Barbara scientists, ... study published in the Journal of Biogeography , ... the opposite may happen: Hosts may actually lose their ...
(Date:7/9/2014)... behind nature,s ability to split the water molecule ... of artificial photosynthesis for clean, green and renewable ... of scientists led by researchers with the Lawrence ... National Accelerator Laboratory. , Working at SLAC,s ... powerful x-ray laser, the researchers were able to ...
Breaking Biology News(10 mins):Not at home on the range 2Not at home on the range 3Not at home on the range 4Postcards from the photosynthetic edge 2Postcards from the photosynthetic edge 3
... long since been a standard animal model for cancer research, ... average and high incidence of cancer. Naked mole rats however, ... rodent has a maximum lifespan exceeding 30 years and most ... single incident of cancer has been detected makes the naked ...
... 31, 2013 Nimbus-Online, Inc. released today a white paper ... reactions to any part of a package while it is ... zero in on specific parts of something a person is ... huge advancement in the science of optical, neural and biometric ...
... dioxide deep underground could at the same be used to ... reservoirs, thus offsetting some of the environmental impact of burning ... the peer-reviewed International Journal of Oil, Gas and Coal ... extracting previously untapped fossil fuel reserves has been in the ...
Cached Biology News:The naked mole-rat's secret to staying cancer free 2If you see a puppy on a package, are you more likely to buy it? 2Sequestration and fuel reserves 2
Tube-O-DIALYZER Floats, small....
Feline Rhinotracheitis Virus...
Ezrin/Radixin/Moesin Antibody...
Rabbit polyclonal to Survivin DEx3 ( Abpromise for all tested applications). entrezGeneID: 332 SwissProtID: O15392...
Biology Products: